Table 2.
Demographic and diagnostic testing for participants with aphasia only (APH∗) who completed the F1 perturbation study (N = 8).
| ID∗ | Sex | Age (years) | Years post-stroke | WAB-AQ (/100) | Aphasia type | PALPA (/72) | E_WIL | PVI_WS |
|---|---|---|---|---|---|---|---|---|
| APH32 |  |
57 | 5 | 63 | Broca | 53 | 0.52 | 141.7 |
| APH78 | |
48 | 3 | 66 | Broca | 63 | 0.05 | 148.2 |
| APH93 | |
36 | 2 | 86.3 | Conduction | 72 | 0.10 | 132.4 |
| APH17 |  |
75 | 4 | 50 | Broca | 72 | 0.05 | 108.6 |
| APH75 | |
73 | 4 | 25.4 | Broca | NA | 0.45 | 114.6 |
| APH87 | |
58 | 18 | 50.8 | Broca | 67 | 0.53 | 119.0 |
| APH90 | |
63 | 1 | 69.2 | Wernicke | 66 | -0.14 | 90.7 |
| APH94 | |
62 | 4 | 59.2 | Conduction | 66 | 0.44 | 112.7 |
| 5
|
M = 59 | M = 5.1 | M = 58.7 | M = 65.6 | M = 0.25 | M = 121.0 | ||
| 3
|
SD = 12.7 | SD = 5.4 | SD = 17.7 | SD = 6.5 | SD = 0.26 | SD = 18.8 | ||
See notes for Table 1. ∗Absence of AOS determined by expert judgment and confirmed by an E_WIL score < 0.17 and/or PVI_WS score > 112 (Ballard et al., 2016); Participants. APH17 reported in New et al. (2015) and APH17, 32, and 75 in Ballard et al. (2016).